(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!
PRODUCT DETAILS
Publisher: Elsevier (Elsevier - Health Sciences Division)
Publication date: September, 2017
Pages: None
Weight: 410g
Availability: Available
Subcategories: Haematology, Oncology
From the same series
